James A Bonner Selected Research

James A Bonner Research Topics

Disease

48	Neoplasms (Cancer) 03/2022 - 11/2002
28	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 07/2002
15	Squamous Cell Carcinoma of Head and Neck 03/2022 - 07/2002
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 09/2009
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2014 - 10/2002
6	Carcinoma (Carcinomatosis) 10/2019 - 07/2002
5	Lung Neoplasms (Lung Cancer) 01/2018 - 11/2002
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2012 - 07/2004
4	Deglutition Disorders (Dysphagia) 01/2021 - 02/2009
3	Glioblastoma (Glioblastoma Multiforme) 06/2019 - 06/2012
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2009 - 11/2002
2	Adenocarcinoma 01/2018 - 03/2015
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2016 - 11/2011
2	Mucositis 01/2016 - 09/2014
2	Exanthema (Rash) 09/2014 - 01/2010
2	Neoplasm Metastasis (Metastasis) 03/2013 - 03/2011
2	Breast Neoplasms (Breast Cancer) 09/2012 - 01/2010
2	Disease Progression 01/2011 - 02/2006
2	Pathologic Constriction (Stenosis) 02/2010 - 02/2009
1	Pain (Aches) 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 10/2019
1	Triple Negative Breast Neoplasms 09/2019
1	Anorexia 09/2014
1	Hypokalemia 09/2014
1	Fatigue 09/2014
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 08/2013
1	Laryngeal Neoplasms (Laryngeal Cancer) 08/2013
1	Ovarian Neoplasms (Ovarian Cancer) 09/2012

Drug/Important Bio-Agent (IBA)

20	Cetuximab (Erbitux)FDA Link 01/2020 - 07/2002
12	ErbB Receptors (EGF Receptor)IBA 01/2020 - 07/2002
9	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 07/2002
6	Pharmaceutical PreparationsIBA 03/2022 - 03/2003
6	Monoclonal AntibodiesIBA 03/2022 - 03/2003
5	Phosphotransferases (Kinase)IBA 03/2022 - 01/2014
4	Biomarkers (Surrogate Marker)IBA 09/2019 - 06/2011
4	Proteins (Proteins, Gene)FDA Link 06/2019 - 01/2011
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 09/2015 - 01/2011
4	veliparibIBA 09/2015 - 01/2011
3	Epidermal Growth Factor (EGF)IBA 01/2020 - 11/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 06/2012
3	Myristoylated Alanine-Rich C Kinase SubstrateIBA 06/2019 - 06/2012
3	Gemcitabine FDA Link 01/2018 - 11/2002
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 09/2015 - 01/2011
3	Biological ProductsIBA 01/2014 - 11/2007
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2010 - 03/2003
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2022 - 01/2020
2	Immune Checkpoint InhibitorsIBA 11/2021 - 09/2019
2	olaparibIBA 01/2020 - 09/2012
2	tyrosine receptor (receptor, tyrosine)IBA 06/2019 - 03/2015
2	PlatinumIBA 12/2017 - 07/2008
2	Peptides (Polypeptides)IBA 03/2015 - 03/2003
2	P 11 (P-11)IBA 08/2012 - 03/2011
2	Small Interfering RNA (siRNA)IBA 06/2011 - 09/2009
2	BariumIBA 02/2010 - 02/2009
2	Ethylene Glycol (Monoethylene Glycol)IBA 01/2010 - 11/2007
2	Taxoids (Taxanes)IBA 01/2010 - 03/2003
2	Tyrosine Kinase InhibitorsIBA 09/2007 - 01/2006
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2007 - 01/2006
2	Etoposide (VP 16)FDA LinkGeneric 07/2007 - 06/2005
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2021
1	LipidsIBA 01/2021
1	LigandsIBA 01/2020
1	8- dibenzothiophen- 4- yl- 2- morpholin- 4- yl- chromen- 4- oneIBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 09/2019
1	pembrolizumabIBA 09/2019
1	AlbuminsIBA 09/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 06/2019
1	TensinsIBA 06/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2019
1	SialyltransferasesIBA 01/2018
1	antineoplaston A10 (A 10)IBA 09/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2015
1	Endothelial Growth FactorsIBA 08/2014
1	pazopanib FDA Link 08/2014
1	Temozolomide (Temodar)FDA LinkGeneric 06/2014
1	O-(6)-methylguanineIBA 06/2012
1	MethyltransferasesIBA 06/2012
1	tigatuzumabIBA 10/2011
1	DNA Repair EnzymesIBA 06/2011

Therapy/Procedure

45	Radiotherapy 01/2022 - 07/2002
16	Drug Therapy (Chemotherapy) 01/2016 - 07/2002
13	Therapeutics 11/2021 - 05/2003
6	Gastrostomy 01/2021 - 02/2009
4	Re-Irradiation 01/2019 - 01/2018
4	Enteral Nutrition (Feeding, Tube) 01/2018 - 03/2012
3	Combined Modality Therapy 01/2021 - 09/2003
3	Cranial Irradiation 01/2011 - 07/2007
3	Aftercare (After-Treatment) 01/2011 - 06/2007
2	Immunotherapy 11/2021 - 09/2019
2	Precision Medicine 09/2019 - 01/2014
2	Tracheostomy 01/2018 - 01/2018
2	Chemoradiotherapy 12/2017 - 11/2011
1	Microspheres (Microsphere) 01/2021
1	Pain Management 01/2021
1	Analgesia 01/2021
1	Particle Accelerators 11/2013
1	Nutritional Support (Artificial Feeding) 03/2012
1	Tracheotomy 10/2011
1	Neoadjuvant Therapy 03/2011